Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Harry S Clarke"'
Autor:
Jackie Mitchell, James Larkin, Noel Kelso, Harry S. Clarke, Paul Nathan, Chris J Sutton, Elizabeth Ruth Plummer, Shien Chow, Philippa Corrie, Paul Lorigan, Dominic G. Rothwell, Samra Turajlic, Alexandra Clipson, Caroline Dive, Richard Marais, Rebecca Lee, Heather Shaw, Gema Sylvestre, N. J. T. Smith
Publikováno v:
Journal of Clinical Oncology. 39:TPS9587-TPS9587
TPS9587 Background: Circulating tumor DNA (ctDNA; the tumour derived fraction of circulating free DNA in the blood) has been shown to be a biomarker of tumor burden/progression in many cancers. We recently accurately monitored treatment response and
Autor:
Amy Sion, Thomas E. Keane, Jennifer Mikoll, Hong Li, Harry S. Clarke, Theodore Stewart Gourdin, Michael B. Lilly, Toros Dincman, Robert L. Grubb, David T. Marshall, Arif Hussain, David Sellman, Stephen J. Savage, Pooja Patel
Publikováno v:
Journal of Clinical Oncology. 39:116-116
116 Background: Randomized trials have demonstrated a survival advantage to administering docetaxel (D) shortly after initiation of androgen deprivation therapy (ADT) in men with newly diagnosed hormone sensitive metastatic prostate cancer (hsMPC). C
Autor:
Ahmed El-Zawahry, Leonie Gordon, William J. Rieter, Harry S. Clarke, Thomas E. Keane, Matthew R. Eskridge, Elizabeth Garrett-Mayer, Georgiana Onicescu
Publikováno v:
Urology. 76:1162-1167
Objectives To evaluate an algorithm using Capromab pendetide scanning (CPS) and prostate biopsy to select appropriate patients with biochemical recurrence (BCR) after radiation therapy (RT) for salvage cryosurgical ablation of the prostate (CSAP) and
Autor:
Marigdalia K. Ramirez-Fort, Christopher S. Lange, Joseph M. Jenrette, Harry S. Clarke, He Liu, Neil H. Bander, M. Junaid Niaz, Goran Rac, Scott T. Tagawa, Sean S. Mahase, Vincent Navarro
Publikováno v:
Cancer Research. 78:1774-1774
Purpose/Objective(s) Prostate-specific membrane antigen (PSMA), also known as folate hydrolase 1 (FOLH1), is a highly specific biomarker and therapeutic target for prostate cancer (PC). J591, a monoclonal antibody specific to PSMA, is the primary met
Publikováno v:
Current Urology Reports. 9:291-294
Open or transurethral resection of the prostate was once the only option for men afflicted with symptomatic benign prostatic hyperplasia (BPH). In the past 10 to 15 years, however, medical management has become a common step in the treatment of BPH,
Autor:
Rabun Jones, Stephen J. Savage, Alyssa Greiman, Kent Armeson, Harry S. Clarke, Robin Bhavsar, Thomas E. Keane, Jaimin Shah, Susan Caulder
Publikováno v:
Urology. 90
Objective To evaluate asymptomatic men with elevated serum prostate-specific antigen (PSA) to determine whether a 6-week course of fluoroquinolone antibiotics lowers serum PSA and affects recommendations for prostate biopsy. Materials and Methods A r
Autor:
Harry S Clarke
Publikováno v:
The American Journal of the Medical Sciences. 314:239-244
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are describ
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 24
A 74 years male with hematuria, mass on digital rectal examination, and elevated prostate specific antigen levels (26 ng/ml) underwent prostate MRI. Imaging demonstrated a prostate mass which contained multiple cystic and solid areas. Subsequent biop
Autor:
David V. Feliciano, Paul Lafontaine, Marcos R. Perez-Brayfield, Thomas E. Keane, Anand Krishnan, Harry S. Clarke
Publikováno v:
THE JOURNAL OF UROLOGY. :119-121
Purpose: Because of the morbidity associated with missed ureteral injuries, a high index of suspicion must be present to diagnose this type of injury. We reviewed our 40 years of trauma experience at Grady Memorial Hospital.Materials and Methods: We